19 results
424B3
PTPI
Petros Pharmaceuticals Inc
14 Jan 22
Prospectus supplement
5:18pm
or clinical trials, which could result in regulatory sanctions and cause serious harm to Petros’ reputation.
Additionally, Petros is subject to the risk … proprietary and confidential information, which could harm our business and reputation or cause us to incur increased expenses to address any
424B5
3b39ayi m6mpz
23 Dec 21
Prospectus supplement for primary offering
5:01pm
424B5
l909s5ic g1
1 Dec 21
Prospectus supplement for primary offering
5:10pm
424B5
njif 634z
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-K
fy61u etk4pf5exiixz
31 Mar 21
Annual report
4:30pm
S-3
kq7n0p3z 2ihefe9ur
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-10.1
y0jrpdn5
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
424B3
mvr4pxkc
2 Nov 20
Prospectus supplement
12:00am
S-4/A
zwllmk70hi1qata0ixt1
30 Sep 20
Registration of securities issued in business combination transactions (amended)
9:21am
S-4
n50cvb
24 Jul 20
Registration of securities issued in business combination transactions
12:00am
- Prev
- 1
- Next